Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-066497
Filing Date
2021-11-23
Accepted
2021-11-23 16:53:02
Documents
2
Period of Report
2021-11-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3625
2 POA DOCUMENT poa.txt EX-24 3390
  Complete submission text file 0001209191-21-066497.txt   8588
Mailing Address 10170 CHURCH RANCH WAY SUITE 100 WESTMINSTER CO 80021
Business Address 10170 CHURCH RANCH WAY SUITE 100 WESTMINSTER CO 80021 7209402200
ARCA biopharma, Inc. (Issuer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021
Business Address
Ozeroff Christopher David (Reporting) CIK: 0001454996 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-22873 | Film No.: 211439238